Scientific article

Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF

October 15, 2019

Cancer Immunol Res

https://pubmed.ncbi.nlm.nih.gov/31597643

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/31597643

Research summary

Key outcome of the study

Model

Highlighted article

TARGET:

Keywords

Technical specifications

Related products

Catalogue product

No items found.

Customized product

No items found.